Situation professionnelle
Résumé
Seasoned Audit Executive with 20+ years of progressive leadership across Internal Audit, Risk Management, Finance, and Corporate Strategy in the global pharmaceutical industry. Proven track record of building high-performing audit teams worldwide, engaging C-suite and Board-level stakeholders, and driving risk-based audits in complex and international environments.
Expériences professionnelles
Head of internal audit commercial operations
Sanofi , Gentilly
De Février 2023 à Aujourd'hui
● Lead the end-to-end audit strategy for all Business Units (Specialty Care, General Medicines, Vaccines), covering worldwide commercial operations.
● Design and execute risk-based audit programs aligned with Sanofi's strategic priorities and regulatory requirements.
● Serve as a trusted advisor to Sanofi Executive Committee, the Executive Compliance Committee, the Audit Committee, and external auditors, providing independent assurance and strategic risk insight.
● Lead and develop a multicultural team of 25 audit professionals across Paris, Singapore, and Shanghai, fostering a high-performance, globally coordinated audit function.
● Board Member of Sanofi European Pension Funds.
Head of internal audit for europe, africa, middle east, eurasia and global support functions
Sanofi , Gentilly
De Février 2022 à Février 2023
● Directed the full audit coverage across a highly diverse, multi-regional scope spanning Europe, Africa, the Middle East, Eurasia, and all Global Support Functions
● Regular interactions with and presentations to Sanofi Executive Committee, Sanofi Audit Committee and Group external auditors.
● Managed and mentored a team of 30 auditors, ensuring consistent audit quality, methodology, and talent development.
Head of sanofi internal audit - americas (north and south america)
Sanofi , New york
De Septembre 2018 à Février 2022
● Directed risk-based audits encompassing R&D, Commercial and Industrial Affairs operations.
● Oversaw a team of 20 auditors providing audit coverage across a $16bn+ revenue region with 20,000 employees, spanning R&D, Commercial, and Industrial operations.
● Regular interactions with and presentations to Sanofi Excom Members, US and Latam Country Councils and Group external auditors.
● Member of Sanofi US Crisis Committee and of the Institute of Internal Auditors (IIA).
Head of financial performance & analysis for the global business unit diabetes and cardio-vascular
Sanofi , Waltham
De Mai 2016 à Septembre 2018
● Drove financial and operational performance management for the €6bn DCV Global Business Unit, delivering strategic insights to the Group CFO and Business Unit leadership.
● Led a team of 5 controllers while orchestrating cross-functional alignment with regional and local CFOs across mature markets.
Cfo sanofi diabetes
Sanofi , Waltham
De Juillet 2014 à Mai 2016
● Financial oversight of Sanofi Diabetes P&L (€7bn of sales) encompassing Commercial operations, Industrial Operations and R&D.
● Management of 4 controllers.
Chief of staff to the chief strategy officer (a member of the group executive committee)
Sanofi , Waltham
De Juillet 2012 à Juillet 2014
Provided strategic and operational support to the Chief Strategy Officer and Group Executive Committee member. Managed complex executive coordination, stakeholder engagement, and strategic initiatives.
Director - head of capital markets and funding
Sanofi , Waltham
De Septembre 2008 à Juillet 2012
● Executed multi-currency bond issuances (USD, EUR, CHF) totaling €12bn, optimizing Sanofi's long-term capital structure.
● Structured and led US$15bn in acquisition bridge financing, including the landmark €20bn Genzyme takeover.
● In charge of the relationships with rating agencies.
● Public offers in the US ($20bn offer on Genzyme plus CVRs), Romania (Zentiva Romania), Poland (Nepentes) and in the Netherlands (Zentiva N.V.)
Parcours officiels
Langues
Anglais - Courant
Espagnol - Notions
Français - Langue maternelle
Compétences
Centres d'intérêt
- Golf
- Photo
- Tennis
linkedin